MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Sonoma Pharmaceuticals EV 2011-2025 | SNOA
EV Jährlich Sonoma Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.57 M | 5.56 M | 8.37 M | 2.76 M | 13.4 M | 9.67 M | 7.59 M | 11 M | 15.5 M | 12.5 M | 4.29 M | 23.8 M | 26.8 M | 33.6 M | 53.8 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 53.8 M | 2.76 M | 15.7 M |
EV anderer Aktien in der Arzneimittelhersteller
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
197 M | - | - | $ 142 M |  USA |
 |
Canopy Growth Corporation
CGC
|
459 M | $ 1.7 | 50.0 % | $ 183 M |  Canada |
 |
Aerie Pharmaceuticals
AERI
|
737 M | - | - | $ 754 M | USA |
 |
Cronos Group
CRON
|
3.84 B | $ 3.24 | 13.51 % | $ 1.69 B | Canada |
 |
Assertio Holdings
ASRT
|
141 M | $ 0.77 | -1.79 % | $ 54.7 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
23.6 M | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
28.5 M | - | 0.86 % | $ 117 M | USA |
 |
Agile Therapeutics
AGRX
|
25.3 M | - | 10.11 % | $ 58.2 M | USA |
 |
Aurora Cannabis
ACB
|
106 M | $ 5.36 | 17.8 % | $ 86.3 M | Canada |
 |
Catalent
CTLT
|
16.7 B | - | - | $ 11.5 B | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
10.2 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
284 M | - | 2.45 % | $ 38.1 M | Canada |
 |
DURECT Corporation
DRRX
|
3.37 M | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
457 M | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
-710 M | - | - | $ 28.9 M |  Irlanda |
 |
Emergent BioSolutions
EBS
|
1.2 B | $ 11.46 | -2.22 % | $ 587 M | USA |
 |
Evoke Pharma
EVOK
|
7.15 M | $ 10.97 | 0.18 % | $ 36.7 M | USA |
 |
Athenex
ATNX
|
209 M | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
756 M | $ 21.38 | -0.05 % | $ 2.03 B |  France |
 |
Evolus
EOLS
|
1.03 B | $ 6.99 | 1.09 % | $ 433 M | USA |
 |
Harrow Health
HROW
|
515 M | $ 47.18 | -7.67 % | $ 1.54 B | USA |
 |
China Pharma Holdings
CPHI
|
11.1 M | $ 1.67 | 11.33 % | $ 29.2 M |  China |
 |
cbdMD
YCBD
|
7.85 M | $ 1.18 | 87.31 % | $ 5.09 M | USA |
 |
Bausch Health Companies
BHC
|
29.9 B | $ 6.95 | -0.93 % | $ 2.54 B | Canada |
 |
OrganiGram Holdings
OGI
|
456 M | $ 1.88 | 14.72 % | $ 402 M | Canada |
 |
Lannett Company
LCI
|
648 M | - | 1.15 % | $ 7.11 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
124 M | $ 2.61 | 4.99 % | $ 36.7 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-110 M | - | - | $ 193 M | Canada |
 |
Organogenesis Holdings
ORGO
|
392 M | $ 4.83 | 1.15 % | $ 636 M | USA |
 |
Pacira BioSciences
PCRX
|
1.68 B | $ 26.28 | 2.14 % | $ 1.22 B | USA |
 |
PetIQ
PETQ
|
280 M | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
170 M | $ 4.12 | -1.67 % | $ 124 M | USA |
 |
Jupiter Wellness
JUPW
|
91.9 M | - | - | $ 33.6 M | USA |
 |
Perrigo Company plc
PRGO
|
8.73 B | $ 13.13 | -2.23 % | $ 1.8 B | USA |
 |
ProPhase Labs
PRPH
|
145 M | $ 0.12 | -15.26 % | $ 1.9 M | USA |
 |
Radius Health
RDUS
|
700 M | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
220 M | - | -4.76 % | $ 65.3 M | USA |
 |
Rockwell Medical
RMTI
|
57.3 M | $ 0.93 | -2.37 % | $ 21.7 M | USA |
 |
Sundial Growers
SNDL
|
-2.47 M | $ 2.19 | 24.01 % | $ 3.37 M | Canada |
 |
OptiNose
OPTN
|
312 M | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
73.8 M | - | -27.8 % | $ 2.56 M | USA |
 |
SCYNEXIS
SCYX
|
91.7 M | $ 0.64 | -0.02 % | $ 30.6 M | USA |
 |
Solid Biosciences
SLDB
|
197 M | $ 5.85 | -0.34 % | $ 239 M | USA |
 |
Tricida
TCDA
|
506 M | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
1.96 B | $ 11.86 | 40.68 % | $ 7.33 B | Canada |
 |
TherapeuticsMD
TXMD
|
33.6 M | $ 1.79 | -2.72 % | $ 18.7 M | USA |
 |
Zomedica Corp.
ZOM
|
137 M | - | -0.21 % | $ 98 M | USA |
 |
Veru
VERU
|
111 M | $ 2.45 | -4.3 % | $ 330 M | USA |
 |
Viatris
VTRS
|
41.3 B | $ 11.63 | 0.3 % | $ 14.1 B | USA |